"Leishmaniasis, Visceral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Descriptor ID |
D007898
|
| MeSH Number(s) |
C03.752.300.500.510
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Visceral".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Visceral".
This graph shows the total number of publications written about "Leishmaniasis, Visceral" by people in this website by year, and whether "Leishmaniasis, Visceral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 4 | 0 | 4 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis, Visceral" by people in Profiles.
-
Leishmania donovani mitogen-activated protein kinases as a host-parasite interaction interface. Cytokine. 2024 07; 179:156627.
-
Myotubularin-related protein 6 is an ion channel-associated pro-leishmanial phosphatase. Int Immunopharmacol. 2024 Mar 10; 129:111644.
-
Myotubularin-related protein-6 silencing protects mice from Leishmania donovani infection. Int Immunopharmacol. 2024 Mar 10; 129:111589.
-
Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani. Cytokine. 2024 02; 174:156475.
-
SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection. Cytokine. 2023 11; 171:156373.
-
Conundrums in leishmaniasis. Cytokine. 2021 09; 145:155304.
-
The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression. Cytokine. 2021 09; 145:155300.
-
The Absence of HIF-1a Increases Susceptibility to Leishmania donovani Infection via Activation of BNIP3/mTOR/SREBP-1c Axis. Cell Rep. 2020 03 24; 30(12):4052-4064.e7.
-
LmjMAPK10 offers protection against Leishmania donovani infection. Parasite Immunol. 2020 02; 42(2):e12687.
-
Expression of a rK39 homologue from an Iranian Leishmania infantum isolate in Leishmania tarentolae for serodiagnosis of visceral leishmaniasis. Parasit Vectors. 2019 Dec 18; 12(1):593.